Chief Financial Officer

Group Finance Director

Finance Manager

Chief Financial Officer at TVM Capital Healthcare Partners Limited & TVM Healthcare Afiyah Fund LP

Jijimon Augustine

TVM Capital Life Science

General Partner

Partner

VP Medical Affairs and Pharmacovigilance

Vice President Clinical Development and Medical Affairs

Vice President Clinical Development

Senior Vice President Clinical Development

Senior VP and Chief Medical Officer

General Partner & CMO at TVM Capital

Marc Riviere

Managing Partner (Finance)

General Partner / CFO

Senior Executive

Managing Partner (Finance) bei TVM Capital Life Science

Stefan Fischer

Managing partner

Luc Marengere

Senior Independent Director

Non Executive Director

Non-Executive Director

Member - Committee of Management

Chair

Vice-Chair and Commissioner

Chair - Board of Directors

President & COO, Board Director

Senior Vice President & General Counsel, various roles

Board Member

Legal Counsel & Corporate Secretary

Independent Non-Executive Director | Governance | Data | Emerging Technologies | Civil Society

Gailina Liew

Director

General Manager

Caretaker

Venture Partner

Director of Animal Health Research

President

Senior Staff Scientist

Consultant DBA Biotechnology Associates

William Topp

VC Investor

Chief of Staff

Healthtech Associate

Project Lead | Consulting & Advisory

EY Global Strategy & Transactions | Embryonic

Health & Life Science VC Investor | PhD (Oxford)

Amy Kao

Geschäftsführender Gesellschafter

Head of Business Development Europe/Germany

Management Consultant

Universitätsdozent

Managing Partner bei TVM Capital

Hubert Birner

Leiter Finanzen

Leiter Finanzen bei TVM Capital

Josef Moosholzer

Assistante exécutive

Coordonnatrice - Ventes & Direction

Coordonnatrice aux ventes

Coordonnatrice à la logistique

Commis aux ventes

Agent de télévente

Dominique Larose

Senior Associate

Associate

Preclinical Development Scientist

Marie Curie Early Stage Researcher

Research Scientist

Laboratory Internship

Senior Associate chez TVM Capital Life Science

Valentina Agostoni

Driver

Driver at TVM Capital

Hasantha Hasantha

Buchhalter

Barbara Hauser

Public Relations Coordinator

Public Relations Coordinator at TVM Capital Group

Sebastian Lopez

Car Driver

sells rep

Aruna Rosi

علاقات عامة

علاقات عامة في TVM Capital

Jamal Alhashmi

3d disigner

3d disigner at TVM Capital

Kimi Chen

business

business at TVM Capital

Farook Am

Private Equity Intern

Investment Banking Analyst

Corporate Banking Intern

Business Development Specialist

Maher Joubeily

Analyst

Research Fellow

Visiting Associate

Medical Congress Support Member

Research Intern

Analyst @ TVM Capital

Paul Kofler

Principal

Chief Executive Officer

President and Chief Executive Officer

Principal at TVM Capital

Ivan Shaw

Senior Associate Venture Capital

Associate Venture Capital

Auf Weltreise / Sabbatical

Investment Banking Analyst (Global Healthcare Team)

M&A Intern

Working Student

Intern

Senior Associate Venture Capital at TVM Capital Life Science

Philipp Lechner

TVM Capital is a venture capital firm that specializes in investments in the life science industry, including biotech, pharmaceuticals, and medical technologies. The company has a long-standing history of providing seed funding, as well as early and later stage financing for innovative companies in the healthcare sector.

TVM Capital

TVM is a leading international venture capital firm focused on investing in life science innovations. The company has a highly experienced transatlantic investment team and approximately $900 million under management. TVM’s portfolio focuses on therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the potential to transform standard of care.

TVM pursues a unique two-pronged strategy, financing innovative early-stage therapeutics through a single asset company approach (Project-Focused Company, PFC) that leverages the firm’s strategic relationship with global pharmaceutical firm, Eli Lilly and Company. TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics.

The TVM investment team has worked together for over a decade to effectively utilize this innovative approach to maximize returns for investors and finance new therapies and technologies to meaningfully improve patient lives.

Bluebird Bio

Abionyx Pharma

Argos Therapeutics

Arteris

Concert Pharmaceuticals

Definiens

Newron Pharmaceuticals

TME Pharma

Vivoryon Therapeutics

Proteon Therapeutics

Rapid Micro Biosystems

F-Star Therapeutics

🚀 Reflecting on an AI Discussion at the LSI USA '24 Emerging Medtech Summit 🚀

Last week's panel Advent of AI: What Will it Take to Drive True Adoption in Clinical Workflows?, moderated by Natasha Allen, Foley & Lardner LLP explored AI’s transformative role in healthcare. Sascha Berger, General Partner at TVM Capital Life Science and other panelists dove into AI's real-world benefits, investment trends and implementation strategies.

 🌐 Highlights:

Clinical Efficiency: Innovations by Vektor Medical, Inc. Medical (TVM portfolio company) and Vista.ai are revolutionizing healthcare workflows, enhancing electrophysiology (EP) lab efficiencies, and making MRIs more accessible.

Real-world Application: Beyond the hype, AI is a practical tool that improves patient care and addresses healthcare workforce shortages.

Investment Growth: The increasing investment in healthcare AI reflects a deeper trust in AI’s capabilities and effectiveness.

Overcoming Challenges: Despite integration hurdles, strategic investments and business models focused on healthcare needs are paving the way for AI’s broader adoption. 

🌟 Takeaway:

The discussion underscored AI's potential to advance healthcare, emphasizing the need for strategic investment and practical implementation strategies. It’s clear that AI is not just a future possibility but a present reality shaping healthcare for the better.

 #HealthcareAI #MedTech #LSIUSA24 #AIInHealthcare #DigitalHealth #LifeScienceInvestment #VC

🚀 Dr. Luc Marengere, will share his expertise and insights at the LSI USA ‘24 Emerging Medtech Summit 2024.

🌟 Don’t miss his panel, “The End of One Road and the Beginning of Another: Transitioning from Pre to Post FDA”. 

This discussion promises to delve deep into the challenges and opportunities that lie in the medtech innovation sphere, especially through the critical phase of FDA approval transitions. It's a unique chance to gain expert insights into how medtech is redefining healthcare standards and what it means for future care.

👉 March 20th | 5:10-5:50pm PST | Track 2

#MedTech #HealthcareInnovation #FDAApproval #HealthTech

🌟 Meet Sascha Berger 🌟, at the LSI USA '24 Emerging Medtech Summit! With his expertise in deal flow generation and pivotal role in recent medtech deals, Sascha will highlight the critical role of AI in healthcare. 

🔍  He will be part of a panel exploring the transformative potential of AI in revolutionizing healthcare, emphasizing the necessity of embracing AI-driven data analysis and technological advancements

👉 March 20th | 1:30-2:10pm PST | Track 3

#Medtech, #HealthTech, #AIinHealthcare, #InnovationInMedicine #FutureOfHealthcare

Revolutionizing Drug Development: A Takeaway from BIO-Europe Spring 2024 🌟

On Day 2 in sunny Barcelona, Hubert Birner engaged in an insightful discussion with Renee T. Williams, PhD MBA, Founder and Managing Partner at Williams Biotech Consulting, LLC, moderated by Emily Mitchell VP, General Partner at ICON plc, highlighting a stark reality: currently about 75% of innovative scientific ideas fail to reach proof-of-concept.

How could our collective mission to improve success rates look?

Two key points:

Collaboration Is Key: 🤝 Success hinges on the dialogue between the asset's originator, VC investors and CROs. Aligning on the strengths each partner brings to the table, common goals and expectations early on is vital.

Leveraging Technology: 💡 The advent of AI and new tech is crucial for boosting clinical development success rates.
 
Our Vision: By fostering strategic partnerships and embracing advanced technologies, TVM Capital Life Science is dedicated to investing in groundbreaking ideas and supporting their transition into clinical realities. 

#BIOEuropeSpring2024 #DrugDevelopment #Innovation

Photo	Title	Links
	Jijimon Augustine Chief Financial Officer
	Marc Riviere General Partner
	Stefan Fischer Managing Partner (Finance)
	Luc Marengere Managing partner
	Gailina Liew Non-Executive Director
	William Topp
	Amy Kao VC Investor
	Hubert Birner Geschäftsführender Gesellschafter
	Josef Moosholzer Leiter Finanzen
	Dominique Larose Assistante exécutive
	Valentina Agostoni Senior Associate
	Hasantha Hasantha Driver
	Barbara Hauser Buchhalter
	Sebastian Lopez Public Relations Coordinator
	Aruna Rosi sells rep
	Jamal Alhashmi علاقات عامة
	Kimi Chen 3d disigner
	Farook Am business
	Maher Joubeily Private Equity Intern
	Paul Kofler Analyst
	Ivan Shaw Principal
	Philipp Lechner Senior Associate Venture Capital

COM:TVM-CAPITAL